Lentitek logo

Lentitek jobs and careers

United Kingdom

About Lentitek

Lentivirus is challenging to manufacture. Unwanted transgene expression and viral genome instability are two common and critical issues. Lentitek can help you solve these challenges through a combination of expert design services and the incorporation of our unique manufacturing technology, which effectively eliminates unwanted transgene expression by stabilising the vector genome during the manufacturing process. Our approach enables you to optimise vector performance, enhance quality and safety, and minimise potentially hazardous off-target effects.

Founded
2019
Employees
1 to 10
Total funding
$250K
Headquarters
United Kingdom

Leadership

The top of Lentitek's org chart, with how many people report into each leader.

AIPhoto of Adam Inche

Adam Inche

Founder